Study on the use of amlodipine liquid in childre
- Conditions
- <p>pediatric hypertension</p>
- Registration Number
- NL-OMON24405
- Lead Sponsor
- Erasmus Medical Centre Rotterdam
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
age between 1 month and 12 years
-signed consent from the parent or legal assent
Exclusion Criteria
-concomitant treatment with another investigational drug within 1 month prior to study entry
-transient, unstable, malignant, or accelerated hypertension
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>pharmacokinetic parameters of the amlodipine liquid</p>
- Secondary Outcome Measures
Name Time Method <p>bloodpressure control, using 24h ambulatory bloodpressure device</p>